Shohei Ohtani

Oct. 1: Ohtani’s surgery was performed today, tweets Maria Guardado of MLB.com.

Sept. 25: Angels starter and DH Shohei Ohtani will undergo Tommy John surgery next week, the club announced to reporters including Jeff Fletcher of the Southern California News Group (via Twitter). While the outcome was expected, it’s nevertheless significant for a player who has emerged this year as an unprecedented dual threat.

Renowned surgeon Dr. Neal ElAttrache will perform the procedure. Ohtani will almost certainly not return to the mound until the 2020 season. Of course, the expectation is that he will continue to function as a hitter for the Angels in 2019.

It’s extremely disappointing to see Ohtani’s first season in the majors draw to a close with surgery awaiting. That said, his continued excellence as a hitter since being shut down as a pitcher certainly leaves plenty of cause for continued excitement, even during his TJ rehab.

Ohtani will be ready to hit far before he’s ready to pitch, of course, so he and the Halos anticipate that he’ll be a full part of the roster next season. (Whether he’ll be ready by Opening Day is, however, not yet certain.) Once he’s ready to do both, Angels GM Billy Eppler recently made clear, he’ll go right back to functioning as a hybrid weapon unlike any other in baseball.

Of course, it’s also worth remembering that damage to Ohtani’s ulnar collateral ligament was evident before he joined the Angels over the winter. When new damage arose in the middle of the 2018 season, Ohtani tried a surgical alternative. But he went down again after ramping back up, making TJS an all-but-foregone outcome.

Ohtani is still putting the finishing touches on his season at the plate, but currently sports an eye-popping .280/.361/.564 slash with 21 home runs in 347 plate appearances. While he only has ten MLB starts under his belt, the 24-year-old has shown ample ability in that area as well. Through 51 2/3 innings, he posted a 3.31 ERA with 63 strikeouts against 22 walks.

With Ohtani on the shelf, and Garrett Richards slated for free agency after another Tommy John surgery of his own the Angels’ rotation is now officially on the look for significant help. The top rotation options heading out of the 2018 season appear to be Andrew Heaney, Tyler Skaggs, Matt Shoemaker, and Jaime Barria.

Sept. 6: Though Tommy John surgery would prevent Ohtani from pitching in 2019, Angels general manager Billy Eppler left no doubt that the Halos still view him as a two-way player in the long run when speaking to reporters in a conference call (link via the OC Register’s Jeff Fletcher).

“We do still see him as a two-way player,” said Eppler. “Shohei has demonstrated the ability to be impactful on both sides of the baseball and that is something that we, and I don’t want to speak for every other team, but I think every team would want impact in the batter’s box and on the mound.”

Eppler didn’t want to commit to the possibility of Ohtani serving as a regular designated hitter for the Angels next year. However, Jeff Passan of Yahoo Sports spoke with four surgeons who “regularly repair torn UCLs,” with each expressing the belief that Ohtani can indeed serve as the Angels’ DH next season — even while recovering from Tommy John surgery. Certainly, each case is unique, but Passan’s column provides a detailed walkthrough of just how and why those medical professionals believe it to be possible.

And, if there was any question as to whether Ohtani can make an impact at the plate as his right elbow mends, the 24-year-old may have given the most emphatic answer possible last night; just hours after the announcement that surgery was recommended, Ohtani went 4-for-4 with a pair of home runs, a walk and a stolen base (video link).

Sept. 5: Tommy John surgery has been “recommended” for Angels starter/DH Shohei Ohtani after an MRI revealed additional damage to his ulnar collateral ligament, the club announced (h/t Jeff Fletcher of the Southern California News Group, on Twitter). It is not yet certain whether he will undergo the surgery, but it certainly sounds as if that will be the case.

Ohtani, 24, has amply justified the hype that formed when it became clear he’d be coming to the majors in advance of the 2018 season. Though some questions formed during his showing in Spring Training, Ohtani has been outstanding both on the mound and at the plate.

While Ohtani has continued to knock the cover off the ball since being diagnosed with a second-degree UCL sprain earlier this year, that development led to obvious concern as to his outlook as a pitcher. He was able to make it back for one outing, showing his typical upper-nineties heat before suddenly dropping off in the third inning.

Whether or not the additional UCL damage occurred during the outing, the fact is that Ohtani will almost certainly miss the entirety of the 2019 season — as a pitcher, that is. Typically, position players are able to return from this particular injury on a much shorter timeline.

It’s important to bear in mind here just why Ohtani was put back on the hill late in a season in which the club was already out of contention. Having received platelet-rich plasma and stem cell treatment, and completed a course of rest and rehabilitation, Ohtani was deemed ready to test the ligament. Had Ohtani instead waited until next spring to take the bump, only then to find that it could not withstand full-throttle pitching, then the recovery timeline would have prevented him from hitting for much or all of the 2019 season and perhaps forced his pitching rehab to push into the 2020 campaign.

The good news for the Angels here is that they are still playing with house money so far as Ohtani is concerned. Because he chose to cross the Pacific before he was eligible to sign outside of the existing MLB international spending caps, he has been limited to a relatively meager signing bonus and the MLB minimum salary. The organization still possesses five full seasons of control beyond the present one.

Still, it’s another hugely disappointing injury for an organization that has had more than its fair share of late. Having already dealt with numerous pitching injuries in recent seasons, this year’s Halos roster went without players such as Zack Cozart, Garrett Richards, and Matt Shoemaker for long stretches. While Shoemaker is now back on track to be a factor in 2019, Richards will hit the open market after succumbing to TJS this summer. The Angels’ front office will face a difficult task in putting together a competitive rotation.

Looking ahead for Ohtani, the news will no doubt re-spark the debate as to whether he would be able to perform as both a pitcher and a hitter at the game’s highest level. Some may now wonder whether that effort will be shelved. But it’s frankly hard to imagine either player or team desiring to cut short what has thus far been an unbelievably successful attempt. In his first attempt at the major leagues, Ohtani has turned in 274 plate appearances of .276/.355/.547 hitting, with 16 home runs and six steals, along with 51 2/3 innings of 3.31 ERA pitching, supported by 11.0 K/9 against 3.8 BB/9.

If anything, perhaps, Ohtani and the Halos will need to assess just how to allow him to perform with the bat in 2018 without jeopardizing his throwing rehab. With nearly six months to go before camp opens, there’s plenty of time for a plan to be mapped out. Though we’ll all be robbed of a chance to see Ohtani’s amazing two-way spectacle for the time being, there’s still reason to hope he’ll be able to resume the grand experiment in 2020.

Angels starter/DH Shohei Ohtani has been cleared medically to resume throwing, per a club announcement. The news came on the heels of his examination after six weeks of rest following stem cell and platelet-rich plasma treatment.

Ohtani, who took MLB by storm in his first season after coming over from Japan, hit the shelf in early June after being diagnosed with a grade 2 sprain of his ulnar collateral ligament. The two-way star has since returned to the active roster to continue working as a hitter, but has not yet begun moving back toward the mound.

It obviously seems to be promising news that Ohtani will be able to attempt to return to the hill as soon as the present season. The announcement states that Ohtani’s UCL “continues to show improved healing.” He’ll doubtlessly be watched closely as he ramps back up and will certainly need some time to get back to full speed. It’ll also be interesting to see how the Halos balance the need to get Ohtani rehab outings with the fact that he’s already an active part of the MLB roster.

Of course, skeptics will note that this club has pursued this route before, with at most a mixed record. While Garrett Richards was able to stave off Tommy John surgery for a while after electing not to undergo the procedure in May of 2016, he experienced some intervening setbacks and only made it back for 22 total starts before ultimately requiring a UCL replacement. Teammate Andrew Heaney initially charted a similar course at nearly the exact same time, but ultimately did not return to competitive action before needing a TJ procedure. Interestingly, though, to this point Heaney has 22 MLB outings of his own since both he and Richards faced the same choice.

It’s worth noting that Ohtani has been cleared to begin ramping up after just six weeks of rest. That’s the same hope that was expressed at the time that Richards underwent his initial treatment, but he ultimately did not begin his own throwing program until mid-August of 2016 — about three months later. Whether that suggests greater cause for optimism in Ohtani’s case isn’t really clear.

Of course, even if Ohtani is able to make it back later this year, it’s far from clear that he’ll have any impact on the team’s 2018 prospects for reaching the postseason. Since he left the rotation, the club has plummeted in the standings and now sits nine games out of a Wild Card spot.

That’s not to say that there isn’t anything to be gained by avoiding the surgery. At this stage of the year, TJ would likely prevent Ohtani from pitching for most or all of the 2019 season. That essential outlook would remain the same if, say, Ohtani ends up undergoing a procedure this fall. The Richards example shows that there are risks in the rehab approach, too, but it’s also far from guaranteed that a pitcher who undertakes such a serious surgery will end up back at full strength.

Fortunately, Ohtani has impressed nearly as much with his bat as with his arm, though it’s the combination of the two areas that makes him utterly unique at the game’s highest level. Through 157 plate appearances, he carries a .283/.365/.522 slash line with seven home runs. In nine starts, he posted a 3.10 ERA with 11.1 K/9 and 3.6 BB/9. The Angels are clearly much better, and the overall game of baseball much richer, with Ohtani functioning in both a hitting and a pitching capacity